Valuation: Haemonetics Corporation

Market Cap 358.02Cr 314.45Cr 292.43Cr 268.35Cr 504.2Cr 34TCr 511.97Cr 3.47TCr 1.36TCr 17TCr 1.34TCr 1.32TCr 59TCr P/E 2027 *
20x
P/E 2028 * 17.7x
Enterprise Value 425.27Cr 373.51Cr 347.36Cr 318.75Cr 598.9Cr 41TCr 608.14Cr 4.12TCr 1.61TCr 20TCr 1.6TCr 1.56TCr 70TCr EV / Sales 2027 *
3.03x
EV / Sales 2028 * 2.69x
Free-Float
98.78%
Yield 2027 *
2.54%
Yield 2028 * -
1 day+1.78%
1 week+1.18%
Current month+5.04%
1 month+1.49%
3 months+31.45%
6 months+14.47%
Current year-1.71%
1 week 74.95
Extreme 74.95
79.57
1 month 71.81
Extreme 71.81
80
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.49
Extreme 29.49
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
05/06/26 Tax

VP, Chief Accounting Officer

-259 0.0006%
05/06/26 Tax

Head of Human Resources

-313 0.0007%
15/05/26 Tax

Executive/Senior Manager

-28,414 0.0611%
Change 5-day change 1-year change 3-year change Capi.($)
+1.78%+1.18%+4.76%-14.16% 358.02Cr
+2.29%+2.36%-18.56%-8.74% 18TCr
+1.46%+0.01%-10.47%-6.46% 11TCr
+1.58%+0.65%+6.73%+61.49% 6.03TCr
-1.13%-2.60%+27.02%+55.00% 5.02TCr
+2.22%-1.14%-15.63%-44.81% 4.31TCr
+2.98%-2.61% - - 3.28TCr
+1.50%-6.67%-19.61%-44.95% 2.76TCr
-7.67%-8.39%+24.55%-12.97% 2.31TCr
+1.63%-1.73%-7.11%-8.13% 2.09TCr
Average +0.66%-1.89%-0.92%-2.64% 5.48TCr
Weighted average by Cap. +1.28%-0.39%-6.73%+1.01%

Financials

2027 *2028 *
Net sales 140.18Cr 123.12Cr 114.5Cr 105.07Cr 197.42Cr 13TCr 200.46Cr 1.36TCr 531.21Cr 6.64TCr 526.25Cr 514.91Cr 23TCr 147.42Cr 129.48Cr 120.41Cr 110.49Cr 207.61Cr 14TCr 210.81Cr 1.43TCr 558.64Cr 6.98TCr 553.42Cr 541.49Cr 24TCr
Net income 18Cr 15Cr 14Cr 13Cr 25Cr 1.7TCr 25Cr 171.07Cr 67Cr 835.06Cr 66Cr 65Cr 2.89TCr 20Cr 18Cr 17Cr 15Cr 29Cr 1.96TCr 29Cr 197.69Cr 77Cr 964.98Cr 77Cr 75Cr 3.34TCr
Net Debt 67Cr 59Cr 55Cr 50Cr 95Cr 6.48TCr 96Cr 652.24Cr 254.82Cr 3.18TCr 252.44Cr 247Cr 11TCr 38Cr 34Cr 31Cr 29Cr 54Cr 3.71TCr 55Cr 373.23Cr 145.82Cr 1.82TCr 144.46Cr 141.34Cr 6.3TCr
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
24/26/24 $78.78 +1.78% 4,62,740
23/26/23 $77.40 -0.81% 5,98,288
22/26/22 $78.03 -0.05% 3,63,405
21/26/21 $78.07 -0.13% 3,71,758
20/26/20 $78.17 +0.40% 5,77,723
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
78.78USD
Average target price
86.60USD
Spread / Average Target
+9.93%

Quarterly revenue - Rate of surprise